Structures by: Selvakumar R.
Total: 37
C8H22Co0.5N8Ni0.5O10
C8H22Co0.5N8Ni0.5O10
New J. Chem. (2016) 40, 1 257
a=6.9096(10)Å b=7.3355(10)Å c=9.5299(13)Å
α=105.577(2)° β=102.494(2)° γ=110.156(2)°
C8H22N8NiO10
C8H22N8NiO10
New J. Chem. (2016) 40, 1 257
a=6.881(4)Å b=7.283(4)Å c=9.541(5)Å
α=105.601(10)° β=102.526(10)° γ=109.834(10)°
C28H23N3O2
C28H23N3O2
Chem.Commun. (2013) 49, 10947
a=11.136(9)Å b=6.875(6)Å c=15.243(12)Å
α=90.00° β=104.490(19)° γ=90.00°
C29H26N2O5
C29H26N2O5
Chem.Commun. (2013) 49, 10947
a=12.7564(7)Å b=11.6471(7)Å c=16.8758(7)Å
α=90.00° β=106.642(3)° γ=90.00°
C8H22CoN8O10
C8H22CoN8O10
New J. Chem. (2016) 40, 1 257
a=6.9244(12)Å b=7.3583(12)Å c=9.5353(16)Å
α=105.537(3)° β=102.545(3)° γ=110.219(3)°
Poly[[triaqua(μ-1,2-dioxocyclobut-3-ene-1,2-diolato)barium] monohydrate]
C4H6BaO7,H2O
Acta Crystallographica Section C (2019) 75, 8
a=6.82160(10)Å b=8.18150(10)Å c=8.80830(10)Å
α=95.146(8)° β=106.652(8)° γ=108.317(7)°
Poly[[diaqua(μ-1,2-dioxocyclobut-3-ene-1,2-diolato)strontium] monohydrate]
C4H4O6Sr,H2O
Acta Crystallographica Section C (2019) 75, 8
a=6.0313(2)Å b=7.7677(3)Å c=8.6375(3)Å
α=101.270(2)° β=94.952(2)° γ=111.578(2)°
Poly[[triaqua(μ-1,2-dioxocyclobut-3-ene-1,2-diolato)barium/strontium(0.85/0.15)] monohydrate]
C4H8Ba0.85O8Sr0.15
Acta Crystallographica Section C (2019) 75, 8
a=6.8271(7)Å b=8.1878(9)Å c=8.8227(9)Å
α=95.18(4)° β=106.64(5)° γ=108.33(4)°
(<i>Z</i>)-3-(4-Methoxybenzylidene)-2,3-dihydrobenzo[<i>b</i>][1,4]thiazepin-4(5<i>H</i>)-one
C17H15NO2S
Acta Crystallographica Section E (2015) 71, 1 o21-o22
a=21.434(5)Å b=5.715(4)Å c=23.870(5)Å
α=90.000° β=101.091(4)° γ=90.000°
Aminoguanidinium hydrogen fumarate
C1H7N4,C4H3O4
Acta Crystallographica Section E (2009) 65, 3 o548
a=6.3869(3)Å b=19.8731(10)Å c=7.0482(4)Å
α=90.00° β=114.688(3)° γ=90.00°
Aminoguanidinium hydrogen succinate
C1H7N4,C4H5O4
Acta Crystallographica Section E (2009) 65, 3 o454
a=15.071(5)Å b=6.565(2)Å c=18.152(5)Å
α=90.00° β=109.733(5)° γ=90.00°
Piperazinediium dioxamate
C4H12N22,2C2H2NO3
Acta Crystallographica Section E (2009) 65, 5 o1004
a=6.4323(4)Å b=6.7681(4)Å c=13.0032(7)Å
α=90.00° β=94.488(2)° γ=90.00°
(<i>Z</i>)-3-(3,4-Dimethoxybenzylidene)-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C18H17NO3S
Acta Crystallographica Section E (2013) 69, 4 o562-o563
a=7.0249(4)Å b=10.7949(7)Å c=10.8826(7)Å
α=91.783(3)° β=97.562(2)° γ=108.512(2)°
(<i>Z</i>)-3-(2,4-Dichlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H11Cl2NOS
Acta Crystallographica Section E (2013) 69, 4 o564
a=7.879(5)Å b=9.667(5)Å c=9.979(5)Å
α=89.052(5)° β=78.161(4)° γ=83.647(5)°
Methyl (<i>E</i>)-3-(2-formylphenoxy)acrylate
C11H10O4
Acta Crystallographica Section E (2014) 70, 6 o709
a=17.7458(8)Å b=4.0629(2)Å c=14.5745(7)Å
α=90.00° β=107.868(3)° γ=90.00°
2-(1,3-Benzothiazol-2-yl)-6-ethoxyphenol
C15H13NO2S
Acta Crystallographica Section E (2011) 67, 9 o2259
a=9.8739(5)Å b=9.6222(4)Å c=13.3644(6)Å
α=90.00° β=95.269(2)° γ=90.00°
(<i>Z</i>)-Methyl 3-(2,4-dichlorophenyl)-2-[(2-formylphenoxy)methyl]acrylate
C18H14Cl2O4
Acta Crystallographica Section E (2011) 67, 10 o2738
a=17.8151(7)Å b=4.9870(2)Å c=18.8418(8)Å
α=90.00° β=97.834(2)° γ=90.00°
(<i>Z</i>)-3-(2-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2283
a=8.4958(3)Å b=8.7197(3)Å c=10.0520(3)Å
α=101.9300(10)° β=95.179(2)° γ=90.314(2)°
(2<i>E</i>,2'<i>E</i>)-Dimethyl 2,2'-[(phenylazanediyl)bis(methylene)]bis(3-phenylacrylate)
C28H27NO4
Acta Crystallographica Section E (2012) 68, 7 o2265
a=9.9099(2)Å b=11.7327(2)Å c=12.4079(4)Å
α=101.131(2)° β=106.039(2)° γ=114.8170(10)°
(<i>Z</i>)-3-(2-Methoxybenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C17H15NO2S
Acta Crystallographica Section E (2012) 68, 7 o2126
a=8.6665(5)Å b=9.7612(4)Å c=10.1328(5)Å
α=108.181(3)° β=101.561(2)° γ=103.217(3)°
(<i>Z</i>)-Methyl 2-[(4-bromo-2-formylphenoxy)methyl]-3-<i>o</i>-tolylacrylate
C19H17BrO4
Acta Crystallographica Section E (2011) 67, 10 o2690
a=8.0114(2)Å b=8.6138(2)Å c=13.4827(4)Å
α=96.4660(10)° β=97.1850(10)° γ=106.546(2)°
(<i>Z</i>)-Methyl 2-bromomethyl-3-(2-chlorophenyl)acrylate
C11H10BrClO2
Acta Crystallographica Section E (2011) 67, 10 o2812
a=10.0657(7)Å b=10.2174(7)Å c=11.3598(7)Å
α=90.00° β=97.649(2)° γ=90.00°
3-[(<i>Z</i>)-Benzylidene]-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2011) 67, 11 o3061
a=10.7711(9)Å b=7.8736(7)Å c=31.610(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-Methyl 2-[(2-ethoxy-6-formylphenoxy)methyl]-3-(4-ethylphenyl)acrylate
C22H24O5
Acta Crystallographica Section E (2011) 67, 12 o3245
a=9.6746(3)Å b=9.9435(3)Å c=10.7935(3)Å
α=77.5950(10)° β=85.433(2)° γ=76.7520(10)°
2-(2<i>H</i>-1,3-Benzodioxol-5-yl)-1,3-benzothiazole
C14H9NO2S
Acta Crystallographica Section E (2012) 68, 4 o961
a=6.3356(2)Å b=16.3222(5)Å c=22.0471(7)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-3-(4-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2130
a=9.0486(3)Å b=9.4105(3)Å c=33.4876(10)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-3-Benzyl-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2012) 68, 8 o2329
a=9.3409(6)Å b=11.7876(7)Å c=11.8310(6)Å
α=90.00° β=94.727(3)° γ=90.00°
2-(2-Nitrophenyl)-1,3-benzothiazole
C13H8N2O2S
Acta Crystallographica Section E (2012) 68, 8 o2362
a=7.6092(2)Å b=12.7854(3)Å c=11.9938(3)Å
α=90.00° β=90.556(2)° γ=90.00°
2-[Hydroxy(2-methoxyphenyl)methyl]acrylonitrile
C11H11NO2
Acta Crystallographica Section E (2012) 68, 8 o2467
a=6.9063(4)Å b=8.7085(4)Å c=11.7294(6)Å
α=94.864(3)° β=98.013(3)° γ=106.579(2)°
(<i>E</i>)-2-[(2-Formylphenoxy)methyl]-3-(4-isopropylphenyl)acrylonitrile
C20H19NO2
Acta Crystallographica Section E (2013) 69, 8 o1354
a=13.3276(9)Å b=11.6435(7)Å c=11.9965(9)Å
α=90.00° β=111.800(3)° γ=90.00°
3-(4-Methoxybenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C17H15NO2S
Acta Crystallographica Section E (2013) 69, 5 o693
a=7.678(5)Å b=9.612(5)Å c=10.860(5)Å
α=77.208(5)° β=74.117(4)° γ=81.522(5)°
(<i>Z</i>)-3-(3,4-Dimethoxybenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C18H17NO3S
Acta Crystallographica Section E (2013) 69, 5 o708
a=19.966(4)Å b=10.355(2)Å c=15.536(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl (2<i>Z</i>)-2-bromomethyl-3-(3-chlorophenyl)prop-2-enoate
C11H10BrClO2
Acta Crystallographica Section E (2013) 69, 6 o852
a=7.4523(3)Å b=11.7003(4)Å c=14.3121(5)Å
α=72.078(2)° β=76.539(2)° γ=76.773(2)°
(<i>E</i>)-2-Bromomethyl-3-(<i>o</i>-tolyl)acrylonitrile
C11H10BrN
Acta Crystallographica Section E (2013) 69, 9 o1367
a=7.5473(8)Å b=11.7362(10)Å c=11.5228(11)Å
α=90.00° β=96.436(3)° γ=90.00°
C26H21NO2S
C26H21NO2S
The Journal of organic chemistry (2016) 81, 8 3391-3399
a=8.7107(2)Å b=10.3413(3)Å c=11.8345(3)Å
α=95.821(2)° β=97.715(2)° γ=93.790(2)°
C25H19ClN2O2S
C25H19ClN2O2S
The Journal of organic chemistry (2016) 81, 8 3391-3399
a=9.5557(2)Å b=10.2960(2)Å c=11.4909(2)Å
α=96.0030(10)° β=104.1560(10)° γ=91.3710(10)°
C24H17NO2S
C24H17NO2S
The Journal of organic chemistry (2016) 81, 8 3391-3399
a=9.4196(2)Å b=20.2974(5)Å c=10.6385(3)Å
α=90.00° β=114.5970(10)° γ=90.00°